Prospera Financial Services Inc Lumos Pharma, Inc. Transaction History

Prospera Financial Services Inc

  • $3.82 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$6.68 - $9.39 $7,267 - $10,216
-1,088 Closed
0 $0
Q1 2022

May 04, 2022
BUY
$6.58 - $10.09 $7,159 - $10,977
1,088 New
1,088 $10,000
Q4 2020

Feb 12, 2021
SELL
$13.61 - $35.91 $14,807 - $39,070
-1,088 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$13.25 - $16.5 $14,416 - $17,952
1,088 New
1,088 $15,000

Others Institutions Holding LUMO

# of Institutions
33
Shares Held
2.2M
Call Options Held
0
Put Options Held
0
View Full List

About LUMOS PHARMA, INC.

LUMO Quotes by TradingView
  • Ticker LUMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,396,070
  • Market Cap $36.4M
  • Description
  • Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...
More about LUMO
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email